INVA FY 2014 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+77.2% YoY

Gross Profit

$935,00011.1% margin

Operating Income

-$34M-402.3% margin

Net Income

-$168M-1997.7% margin

EPS (Diluted)

$-1.50

Cash Flow

Operating Cash Flow

-$131M

Free Cash Flow

-$131M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$522M

Total Liabilities

$745M

Stockholders' Equity

-$223M

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+77.2%
Gross Profit	$935,000	-$4M	+121.8%
Operating Income	-$34M	-$169M	+79.9%
Net Income	-$168M	-$171M	+1.3%